Finance

Beta
Ask
Lists
SMMT:NASDAQ
Summit Therapeutics Inc
$13.75
-2.27%
(-0.32) 1D
$13.75
0.00% (0.00)
After hours
Closed: Jun 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SMMT...
Open
$14.38
High
$14.60
Low
$13.56
Mkt. cap
10.67B
Avg. vol.
5.64M
Volume
8.72M
52-wk high
$30.98
52-wk low
$12.55
EPS
-$1.60
Beta
-1.32
Shares outstanding
776.16M
No. of employees
265
Open
$14.38
High
$14.60
Low
$13.56
Mkt. cap
10.67B
Avg. vol.
5.64M
Volume
8.72M
52-wk high
$30.98
52-wk low
$12.55
EPS
-$1.60
Beta
-1.32
Shares outstanding
776.16M
No. of employees
265
Analyst outlook
Analyst Ratings
Based on 13 analysts giving stock ratings to SMMT in the past 3 months
Buy
Buy
8
Hold
4
Sell
1
12 month forecast
Based on 13 Wall Street analysts offering 12 month price targets for SMMT in the last 3 months.
Highest
Current $13.75
$45.00 (+227.27%)
Average
$29.06 (+111.35%)
Lowest
$7.70 (-44.00%)
News stories
From sources across the web
About Summit Therapeutics Inc
CEORobert Duggan | Maky Zanganeh
Employees265
Founded2003
Headquarters-
SectorBiotechnology
Websitesmmttx.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
208.02M
131.10M
147.29M
132.62M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
360.42M
103.12M
77.63M
62.59M
Operating expense
568.44M
234.21M
224.92M
195.21M
Total operating expenses
568.44M
234.21M
224.92M
195.21M
Operating income
-568.44M
-234.21M
-224.92M
-195.21M
Other non operating income
-53.00K
-
-
-
EBT including unusual items
-565.71M
-231.79M
-219.17M
-189.42M
EBT excluding unusual items
-565.71M
-231.79M
-219.17M
-189.42M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-565.71M
-231.79M
-219.17M
-189.42M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.98M
2.78M
5.88M
5.85M
Interest expense
-
-
-
-
Net interest expenses
2.98M
2.78M
5.88M
5.85M
Depreciation and amortization charges
-
-
-
-
EBITDA
-568.40M
-234.17M
-224.88M
-195.17M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer